Our Vision
To advance Clinical & Translational Research Solutions that turn complex environmental-exposure and pulmonary diagnostic science into real-world impact for patients, health systems, and partners — translating scientific discovery into clinically relevant strategies for healthcare, biotechnology, diagnostic, and research organizations.
Our Mission
JACDA, LLC provides Clinical & Translational Research Solutions by designing smarter clinical and translational studies, advancing diagnostic development, and strengthening scientific grants and training — with a focused specialty in environmental exposure and pulmonary/respiratory disease risk. Founded by Diane S. Allen-Gipson, Ph.D., M.S., we support Biotechnology & Life Sciences Startups; Diagnostic & Medical Technology Companies; Academic Researchers; and Healthcare Organizations to move diagnostics from concept to impact.
Founder & CEO
Diane S. Allen-Gipson, Ph.D, M.S.
Founder & CEO — Associate Professor (tenured), USF Health Taneja College of Pharmacy; Vice Chair, Dept. of Pharmaceutical Sciences (2024–2026).
Dr. Allen-Gipson brings 20+ years of NIH-, NSF-, and VA-funded research in pulmonary and airway epithelial biology to JACDA's diagnostic strategy. Her record includes 59+ peer-reviewed publications in pulmonary and airway biology, 2 patent applications (nanoparticle-based tumor imaging; lupus immunomodulation), and a funding history spanning NIH K01, VA Merit Review, NSF, and Florida Department of Health awards.
Ph.D., Pharmaceutical Sciences · M.S., Pharmacology & Toxicology · B.S., Biological Science
Who We Work With
JACDA, LLC supports organizations across the clinical, diagnostic, and research ecosystem.
CROs
Medical writing companies
Grant consultants
Regulatory consultants
Biotech incubators
University technology-transfer offices
Startup accelerators
Contract laboratories
Pulmonology & environmental medicine practices
Intellectual-property firms